EMOttawa Blog
  • Ottawa Handbook of Emergency Medicine
  • EMOttawa Podcast
  • Point-of-Care Echo
  • Grand Round Summaries
  • Journal Club
  • Commentary
  • Ultrasound
  • Infographics
  • Canadian TIA Score
  • EDI
  • Prehospital and Transport Medicine
  • Ottawa Acute Care Resources
  • About Us
Select Page
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage

by Courtney Price, Hans Rosenberg, Krishan Yadav | Jan 27, 2025 | Full Article, Journal Club, Neurology, Neurosurgery, Thrombosis

Methodology 3/5 Usefulness 3/5 Connolly SJ, et al. N Engl J Med. 2024 May 16;390(19):1745-1755.  Editorial: Reversing Oral Anticoagulation in Intracerebral Hemorrhage.  Question and Methods: This unblinded, multicentre randomized controlled trial studied whether...
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

by Hans Rosenberg | May 13, 2019 | Journal Club, Thrombosis

Journal Club Summary Methodology: 2.5/5 Usefulness: 2/5 Connolly SJ, et al. N Engl J Med. 2019 Feb 7. Question and Methods: This was the first trial looking at clinical outcomes for reversal of factor Xa inhibitor anticoagulation in major bleeding episodes using the...
  • Facebook
  • Twitter
  • Instagram
  • YouTube

Mission Statement

World-Class Emergency Medicine: To provide outstanding compassionate emergency care through practice-changing research and innovative medical education. For more about our department, visit us at EMOttawa.

Categories

Mission Statement

World-Class Emergency Medicine: To provide outstanding compassionate emergency care through practice-changing research and innovative medical education. For more about our department, visit us at EMOttawa.

Categories

Archives

Free Open Access Medical Education content by EMOttawa is under a Creative Commons Attribution-NonCommercial ShareAlike 4.0 International License.